Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CleanUp-IPF
NCT02759120Phase 3Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Mar 2017
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trimethoprim + sulfamethoxazole, doxycycline in idiopathic pulmonary fibrosis (IPF), sponsored by Weill Cornell Medicine. Started Mar 2017; status: terminated.
02
Drugs
trimethoprim + sulfamethoxazoledoxycycline
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT02759120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02759120.